Overview:

We are excited to share our latest Global Oligonucleotide Synthesis Market Company Blog 2024, offering in-depth insights into this dynamic and rapidly evolving industry. This comprehensive report covers market size, trends, growth drivers, challenges, and competitive landscape, tailored to empower your strategic decision-making.

The Oligonucleotide Synthesis market research report comprises a thorough examination of the current and future scenario of this industry vertical. The research highlights major trends and opportunities, as well as challenges, for various segments and sub-segments, while broadening the company horizon. The study report also includes extensive information based on past and present patterns across several industry verticals to help find various expansion prospects. Throughout the forecast period, several estimations regarding market share, market size, and industry growth rate are presented. The research includes information on competitive analysis as well as consumption habits and pricing strategies depending on the Oligonucleotide Synthesis market.

Pick up the report: https://bit.ly/4eP8oMe

Top 10 Leading Companies

Thermo Fisher Scientific

Headquarters: Waltham, Massachusetts, USA

Founded: 1956

Employees: ~125,000 (2023)

Revenue (2023): ~$44 billion

Overview: Thermo Fisher Scientific is a global leader in providing innovative solutions for the scientific community, with a significant impact across various industries, including healthcare, life sciences, and environmental research.

Regional Focus

• North America: Leading region for Thermo Fisher's operations due to its strong research infrastructure and partnerships with biotech firms.
• Europe and Asia-Pacific: Growing markets fueled by increased R&D spending in biotechnology and life sciences.

Integrated DNA Technologies (IDT)

Headquarters: Coralville, Iowa, USA

Founded: 1987

Employees: ~2,000

Revenue (2023): ~$500 million

Overview: Integrated DNA Technologies (IDT) is a leading provider of custom oligonucleotides and nucleic acid solutions, catering to the needs of researchers and developers in genomics, molecular biology, and therapeutic applications.

IDT specializes in high-quality, custom oligonucleotides, catering to diagnostics, genomics, and therapeutic needs. Their innovations include CRISPR-related products and RNA-based solutions.

Regional and Global Presence

• North America: IDT has a robust presence in the U.S., focusing on partnerships with academic institutions, biotech firms, and pharmaceutical companies.
• Europe and Asia-Pacific: Growing demand for precision diagnostics and therapeutic oligos has driven expansion in these regions.

Agilent Technologies

Headquarters: Santa Clara, California, USA

Founded: 1999

Employees: ~18,000

Revenue (2023): ~$7 billion

Overview: Agilent Technologies is a global leader in analytical instrumentation, life sciences, diagnostics, and applied chemical markets, playing a vital role in advancing the oligonucleotide synthesis market through its innovative technologies and solutions. Agilent is a key provider of synthetic oligonucleotides and reagents, supporting applications in molecular diagnostics, gene synthesis, and drug development.

Regional Focus

• North America: Agilent maintains a strong foothold in the U.S., driven by partnerships with research institutions and biopharmaceutical companies.
• Europe: Growth fueled by demand for gene therapies and advancements in molecular biology.
• Asia-Pacific: Rapid expansion due to increased biotechnology research and government investments in R&D.

Merck KGaA (MilliporeSigma)

Headquarters: Darmstadt, Germany

Founded: 1668

Employees: ~64,000

Revenue (2023): ~$23 billion

Overview: Merck KGaA, operating in the U.S. and Canada under the name MilliporeSigma, is a global leader in life sciences and biotechnology. It plays a pivotal role in advancing the oligonucleotide synthesis market, offering innovative tools, services, and reagents for a variety of applications in pharmaceuticals, diagnostics, and research.

Regional Market Focus

• North America: Major growth area driven by partnerships with leading biotech companies and academic institutions.
• Europe: Strong demand for pharmaceutical-grade oligonucleotides, especially for gene and RNA therapies.
• Asia-Pacific: Rapid market expansion due to government investments in biotechnology and increasing R&D activities.

Bio-Rad Laboratories

Headquarters: Hercules, California, USA

Founded: 1952

Employees: ~8,300

Revenue (2023): ~$2.8 billion

Overview: Bio-Rad Laboratories is a globally recognized leader in providing innovative oligonucleotide synthesis technologies for applications in qPCR, sequencing, and molecular biology. The company plays a vital role in the oligonucleotide synthesis market, offering advanced tools and reagents for research, diagnostics, and therapeutic applications.

Regional Market Presence

• North America: Dominant market driven by strong research infrastructure and collaborations with biotech firms.
• Europe: Growth driven by advancements in molecular diagnostics and pharmaceutical applications.
• Asia-Pacific: Emerging market fueled by increasing R&D investments in biotechnology.

LGC Biosearch Technologies

Headquarters: Teddington, UK

Founded: 1842

Employees: ~3,000

Revenue (2023): ~$600 million

Overview: LGC Biosearch Technologies is a leading provider of high-quality reagents, oligonucleotides, LGC supports genetic analysis, molecular diagnostics, and therapeutic development with cutting-edge solutions. The company has a strong presence in the oligonucleotide synthesis market, catering to research, diagnostics, and therapeutic development.

Regional Market Focus

• Europe: Home to its headquarters, LGC has a strong presence in the EU, supported by its research-driven ecosystem.
• North America: A growing market due to increased demand for molecular diagnostics and synthetic biology.
• Asia-Pacific: Expanding operations due to investments in biotechnology and research infrastructure.

GenScript Biotech Corporation

Headquarters: Nanjing, China

Founded: 2002

Employees: ~6,000

Revenue (2023): ~$1 billion

Overview: GenScript Biotech Corporation is a leading global biotechnology company specializing in gene synthesis, oligonucleotide manufacturing, and molecular biology services. The company is a prominent player in the oligonucleotide synthesis market, supporting applications in research, diagnostics, and therapeutic development.

Regional Market Presence

• Asia-Pacific: Dominant position in China and neighboring markets due to its strong local presence and manufacturing capabilities.
• North America: Expanding operations to cater to high demand in the biotech and pharmaceutical sectors.
• Europe: Growing footprint in the synthetic biology and molecular diagnostics market.

Eurofins Genomics

Headquarters: Ebersberg, Germany

Founded: 1987

Employees: ~61,000 (Eurofins Group)

Revenue (2023): ~$7.8 billion (Eurofins Group)

Overview: Eurofins Genomics is a globally recognized provider of genomic services, including oligonucleotide synthesis, next-generation sequencing, and molecular biology solutions. The company plays a significant role in the oligonucleotide synthesis market, delivering customized, high-quality DNA and RNA products for diverse applications.

Regional Market Focus

• Europe: Home to its headquarters and largest market presence, driven by strong demand for genomic tools and healthcare applications.
• North America: Expanding operations to meet increasing needs in biotechnology, healthcare, and academic research.
• Asia-Pacific: Growth fueled by investments in genomics and biopharmaceutical research.

TriLink BioTechnologies

Headquarters: San Diego, California, USA

Founded: 1996

Employees: ~500

Revenue (2023): ~$150 million

Overview: TriLink BioTechnologies, a Maravai LifeSciences company, is a key player in the oligonucleotide synthesis market, specializing in nucleic acid-based products and services. It is widely recognized for its contributions to mRNA synthesis, nucleotides, and custom oligos for use in research, diagnostics, and therapeutics.

Regional Market Presence

• North America: A dominant player in the U.S., driven by demand for mRNA technology and nucleic acid-based diagnostics.
• Europe: Expanding presence, supported by collaborations with pharmaceutical companies and biotech firms.
• Asia-Pacific: Growing market due to increasing investments in synthetic biology and therapeutic nucleic acids.

Bio-Synthesis Inc.

Headquarters: Lewisville, Texas, USA

Founded: 1984

Employees: ~200

Revenue (2023): ~$30 million

Overview: Bio-Synthesis Inc. is a specialized biotechnology company providing custom synthesis of DNA, RNA, peptides, and other biomolecules for various applications, including research, diagnostics, and therapeutics. It has a strong presence in the oligonucleotide synthesis market, serving academic, clinical, and industrial clients.

Regional Market Focus

• North America: Dominates in the U.S. with a focus on academic and industrial research.
• Europe: Expanding presence to meet growing demand for molecular diagnostics and synthetic biology.
• Asia-Pacific: Emerging market driven by collaborations in biotech and pharmaceutical industries.

Unlock the Full Report: https://bit.ly/4eYPcMg

Contact Us:
Follow Us: LinkedIn
Email: sales@intellectualmarketinsights.com
Call Us: +1 (814) 487 8486